Intuitive Surgical, Inc. $ISRG Shares Sold by Impax Asset Management Group plc

Key Points

• Institutional and insider selling: Impax Asset Management cut its stake by 6.7% to 199,525 shares (about $113.0M) and, overall, insiders have sold 32,943 shares worth $17.28M in the past 90 days while institutional investors own 83.64% of the stock.
• Strong Q1 results and analyst reaction: Intuitive beat estimates with EPS $2.50 vs. $2.08 and revenue $2.77B (+23% YoY), prompting bullish analyst moves and an average price target of about $581.91 amid mixed ratings (18 Buy, 7 Hold, 1 Sell).
• Operational risks to monitor: Product recalls of reusable da Vinci instruments and emerging competition (e.g., J&J) — plus a contained cyber incident — could pressure service/consumables revenue and customer confidence.

Impax Asset Management Group plc lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 6.7% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 199,525 shares of the medical equipment provider's stock after selling 14,248 shares during the quarter. Impax Asset Management Group plc owned about 0.06% of Intuitive Surgical worth $113,003,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in ISRG. Holos Integrated Wealth LLC acquired a new position in Intuitive Surgical during the 4th quarter worth $25,000. Newbridge Financial Services Group Inc. raised its position in shares of Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 33 shares during the period. Greykasell Wealth Strategies Inc. acquired a new stake in shares of Intuitive Surgical during the third quarter worth $27,000. Olistico Wealth LLC acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth $28,000. Finally, Caitlin John LLC acquired a new position in Intuitive Surgical during the third quarter valued at $30,000. Institutional investors and hedge funds own 83.64% of the company's stock.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Q1 beat and accelerating growth — ISRG reported a better-than-expected Q1 (EPS $2.50 vs. $2.08 consensus) with ~23% revenue growth and commentary pointing to rising procedures and an improved outlook, which underpins the stock's upside today. Intuitive Surgical Beats Q1 — TipRanks
• Positive Sentiment: Innovation and pricing power — Coverage notes revenue is outpacing procedures as the da Vinci 5 platform drives higher ASPs and service/consumable mix, supporting margin and longer-term upside. Innovation-Led Growth — Zacks
• Positive Sentiment: Analyst support — Several sell‑side actions are favorable: Robert W. Baird raised its price target to $610 and BTIG reaffirmed a Buy; Goldman published a bullish outlook, adding conviction to the post‑earnings rally. Baird Raises PT — AmericanBankingNews BTIG Reaffirms Buy — AmericanBankingNews
• Neutral Sentiment: Mixed analyst moves — Some firms trimmed targets (Jefferies to $515, Leerink and others adjusted targets), leaving consensus views varied; this increases volatility around near‑term price action. Jefferies Lowers PT — AmericanBankingNews
• Neutral Sentiment: Short interest signal is uninformative — April data reported no meaningful short interest (0 shares reported), so short-squeeze risk appears minimal based on the published figures.
• Neutral Sentiment: Contained cyber incident disclosed — Management reported a contained cyber event with remediation underway; investors will watch disclosures but the company says operations are not materially disrupted. Cybersecurity and Q1 Coverage — Yahoo
• Negative Sentiment: Instrument recalls raise reliability questions — ISRG initiated multiple recalls of reusable da Vinci instruments after safety complaints (fraying/broken cables); recalls could pressure service/consumables revenue and hospital confidence if issues persist. Recalls and Revenue Risk — Yahoo
• Negative Sentiment: Competition creeping in — Johnson & Johnson earned CE mark for a stapler that integrates with Ottava, signaling incremental competition in the surgical robotics ecosystem that investors should monitor. J&J CE Mark — MedTechDive

Insider Buying and Selling

In related news, VP Fredrik Widman sold 133 shares of the stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $65,829.68. Following the completion of the sale, the vice president owned 660 shares in the company, valued at $326,673.60. This represents a 16.77% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Patricia L. Wadors sold 220 shares of the stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $499.71, for a total value of $109,936.20. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 32,943 shares of company stock worth $17,279,568. Insiders own 0.60% of the company's stock.

Wall Street Analyst Weigh In

Several research firms recently weighed in on ISRG. Wall Street Zen lowered Intuitive Surgical from a "buy" rating to a "hold" rating in a research report on Saturday, February 7th. Argus dropped their price target on Intuitive Surgical from $630.00 to $560.00 and set a "buy" rating on the stock in a research report on Wednesday, February 4th. Mizuho set a $525.00 target price on Intuitive Surgical and gave the company a "neutral" rating in a research note on Monday, April 13th. UBS Group lowered their target price on Intuitive Surgical from $570.00 to $550.00 and set a "neutral" rating on the stock in a research note on Tuesday, March 17th. Finally, Barclays set a $651.00 target price on Intuitive Surgical and gave the company an "overweight" rating in a research note on Thursday. Eighteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $581.91.

Intuitive Surgical Stock Performance

ISRG opened at $482.22 on Friday. The company has a market cap of $170.78 billion, a PE ratio of 58.45, a price-to-earnings-growth ratio of 4.09 and a beta of 1.68. The stock has a 50-day moving average of $477.47 and a 200-day moving average of $515.38. Intuitive Surgical, Inc. has a 52-week low of $427.84 and a 52-week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.08 by $0.42. The company had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The firm's revenue was up 23.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.81 EPS. On average, research analysts predict that Intuitive Surgical, Inc. will post 8.2 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.